Silver Birch (Bet v 2) IgE Test · Blood

If you react to birch pollen and also feel symptoms from grass, weeds, or certain raw fruits and vegetables, this test can help explain why. Bet v 2 (the formal name for birch profilin) is a small protein that looks nearly identical across hundreds of plants, so IgE antibodies against it tend to cause reactions to many sources at once.

This is not a stand-alone birch allergy test. It is a phenotype indicator that distinguishes someone with true, focused birch allergy from someone whose immune system is reacting to a cross-reactive protein family. That distinction shapes what triggers you, what foods you tolerate, and whether allergy shots are likely to work.

What This Test Actually Measures

The test detects IgE antibodies in your blood that bind to Bet v 2 (birch profilin), a structural protein found inside plant cells. Profilin is described as a pan-allergen because nearly identical versions exist in grass pollen, weed pollen, and many fruits and vegetables. IgE is the antibody class your immune system makes during allergic reactions, produced by specialized white blood cells called B cells.

When this number is detectable, it means your immune system has built antibodies against profilin specifically, not against the main birch allergen Bet v 1. The two markers behave very differently in the body and point to different clinical patterns.

Why Bet v 2 Differs From Bet v 1

Birch pollen contains several distinct allergens. Bet v 1 is the major one and is tightly linked to classic birch allergy, including the apple, cherry, and stone fruit reactions known as oral allergy syndrome. Bet v 2 is a minor allergen, present in fewer birch-allergic people and almost never seen in patients who react only to birch.

In a study of 372 birch-allergic adults in Italy, 44 to 46 percent had IgE to Bet v 2, while 58 to 92 percent had IgE to Bet v 1. In a Japanese cohort of 40 birch-allergic patients, only about 15 percent had Bet v 2 IgE, while Bet v 1 dominated. The pattern is consistent: Bet v 1 marks primary birch allergy, Bet v 2 marks something broader.

What It Means to Have Bet v 2 IgE

Detectable Bet v 2 IgE strongly suggests polysensitization, meaning your immune system has built reactions to multiple pollen sources rather than birch alone. In a Japanese cohort, every single Bet v 2-positive patient also had higher rates of sensitization to mites, grass, and mugwort. A study of 500 allergic patients found polysensitization in 81 percent of them, and this pattern was linked to more severe asthma and rhinitis symptoms.

Importantly, sensitization to Bet v 2 alone was not associated with clear birch pollen symptoms in clinical research. The antibodies are there, but the link to symptoms is weaker and less specific than with Bet v 1. This is why interpretation depends on the full picture, not this one number.

Pollen-Food Cross-Reactivity

Profilin sits inside many raw fruits, vegetables, and tree nuts, which is why people sensitized to it sometimes experience tingling, itching, or swelling in the mouth after eating melon, citrus, banana, or tomato. A study of 1,119 birch-sensitized patients found that those who had IgE to both Bet v 1 and profilin had a higher likelihood of oral allergy syndrome, intestinal reactions, and rhinitis symptoms than those with Bet v 1 alone.

That said, profilin-driven food reactions tend to be mild and often disappear with cooking, since heat destroys the protein's shape. Bet v 1, not Bet v 2, remains the stronger predictor of food allergy patterns in birch-sensitized people.

Implications for Allergy Shots

Allergen immunotherapy (allergy shots or sublingual tablets) for birch pollen is built around Bet v 1. Patients with IgE to Bet v 1, with or without Bet v 2, are considered good candidates. Those who test positive only for Bet v 2 or other minor birch components without Bet v 1 are typically less suitable, because birch-targeted therapy will not address the broader profilin sensitization driving their symptoms.

This is the most actionable use of the Bet v 2 result. It changes who gets which treatment, and it can prevent months of immunotherapy that would not move the needle on symptoms.

Why a Single Result Is Not Enough

IgE sensitization patterns shift over time, especially in childhood and during ongoing pollen exposure. A study in northern China found that profilin sensitization patterns vary by region and likely by exposure intensity. Your antibodies today reflect the immune system's current state, not a fixed verdict.

If you are starting or stopping immunotherapy, moving to a new climate, or developing new food sensitivities, retesting can show how your immune response is evolving. A reasonable cadence is a baseline test, a follow-up after about 6 to 12 months if symptoms change, and at least every 1 to 2 years if you are tracking treatment response. Single readings are useful for diagnosis but trends tell you whether anything is shifting.

What to Do With an Unexpected Result

If your Bet v 2 IgE comes back detectable but you only have classic birch symptoms, that does not automatically mean you have new allergies. It means your immune system is producing cross-reactive antibodies that may or may not cause symptoms. The next step is testing for Bet v 1 to see if you have true birch sensitization alongside the profilin pattern, plus IgE to other pollen components like Phl p 12 (grass profilin) if you have grass symptoms.

If your result is positive and you have multiple, hard-to-explain allergies, an allergist or immunologist can use the full component profile to map out what is genuinely driving symptoms versus what is cross-reactivity. This typically involves component-resolved diagnostics, where a panel of individual allergen proteins is tested at once. The combination of findings, not Bet v 2 alone, determines whether immunotherapy is appropriate, which triggers to avoid, and whether food reactions are likely to be mild and self-limiting or worth pursuing further.

When Results Can Be Misleading

A detectable Bet v 2 IgE does not always mean active allergy. Studies have shown that allergen-specific IgE levels do not always match skin sensitivity or symptom severity. You can be sensitized on paper without having clinical reactions, and the converse can occur too.

• Cross-reactive carbohydrate determinants: these are sugar structures shared across many plants and insects that can produce false-positive IgE results in pollen extract tests, though component tests like Bet v 2 are designed to minimize this.
• Recent allergen exposure: sensitization patterns can shift during and after heavy pollen seasons, so the same person may show different IgE profiles in spring versus winter.
• Lab method differences: different testing platforms can give different numerical values for the same sample, so trending matters more when using the same lab over time.
• Sensitization without symptoms: detectable IgE means your immune system recognizes the protein, not that you will react to it clinically.

How This Fits With Other Allergy Testing

Skin prick testing with whole birch extract remains the most sensitive screening tool for birch allergy and identifies more sensitized people than component IgE testing alone. The Bet v 2 test adds something different: precision about which protein is driving your immune response, which extract testing cannot reveal. Combined with Bet v 1 and other component tests, it builds a clearer picture of whether you have primary, focused allergy or a profilin-driven cross-reactive pattern.

Recombinant tests using Bet v 1 plus Bet v 2 together identified about 90 percent of birch-sensitized patients in a 372-person Italian cohort, and combining Bet v 1 with whole birch extract reached close to 99 percent sensitivity for tree pollen rhinoconjunctivitis. Bet v 2's specific job within that workup is to flag cross-reactivity, not to diagnose birch allergy on its own.